How does NR4A2 mechanistically regulate the transition from inflammatory to pro-neurogenic microglia phenotype?

OPEN

NR4A2 is identified as promoting anti-inflammatory, pro-neurogenic microglia, but the downstream molecular pathways and targets remain unclear. Understanding this mechanism is critical for developing interventions to enhance endogenous brain repair. Gap type: unexplained_observation Source paper: Adult human subventricular zone microglia promote a pro-neurogenic niche for neuronal progenitors in Parkinson's disease. (2025, Brain, behavior, and immunity, PMID:40516636)

Priority: 0.83 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does NR4A2 mechanistically regulate the transition from inflammatory to pro-neurogenic microglia phenotype? is a 0.83 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does NR4A2 mechanistically regulate the transition from inflammatory to pro-neurogenic microglia phenotype? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (12)

NR4A2CardiovascularNR4A2MsNR4A2AtherosclerosisNR4A2CancerNR4A2Cardiac
▸ Show 7 more

biomarker for (25)

NR4A2ALSNR4A2AtherosclerosisNR4A2FibrosisNR4A2InflammationNR4A2Als
▸ Show 20 more

inhibits (2)

NR4A2IschemiaNR4A2Tumor

regulates (2)

GABRA2NR4A2JAKNR4A2

therapeutic target (9)

NR4A2GlioblastomaNR4A2MsNR4A2DiabetesNR4A2InflammationDIABETES MELLITUSNR4A2
▸ Show 4 more
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps